U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07217899) titled 'Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony' on Oct. 14.
Brief Summary: This research study is being done to learn what effect a single dose of calcium gluconate will have on blood loss at the time of cesarean delivery in pregnancy patients at high risk for uterine atony.
Study Start Date: Oct. 15
Study Type: INTERVENTIONAL
Condition:
Blood Loss, Surgical
Blood Loss, Postoperative
Uterine Atony
Intervention:
DRUG: Calcium Gluconate
slow push intravenous administration of 2g calcium gluconate- 20 mL of 10% Calcium Gluconate i...